Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C8ES
|
|||
| Former ID |
DIB012967
|
|||
| Drug Name |
CBL0102
|
|||
| Indication | Hepatocellular carcinoma [ICD-11: 2C12.02; ICD-10: C22.0; ICD-9: 155] | Phase 1/2 | [1] | |
| Company |
Cleveland biolabs
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Facilitates chromatin transcription complex (FACT) | Target Info | Modulator | [2] |
| WikiPathways | HIV Life Cycle | |||
| RNA Polymerase II Transcription | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025385) | |||
| REF 2 | Company report (Incuron) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.